HPB Flashcards
Causes of acute hepatitis
Viral infection: Hep A-E, non-hep
Autoimmune
Drug reactions
Alcohol
Chronic causes
Hep B +/- hep D Hep C Autoimmune hepatitis Alcohol Hyperlipidaemia (NAFLF) Drugs (methyldopa/nitrofurantoin) Metabolic: wilson's disease, alpha-1-antitrypsin deficiency, haemachromatosis
Components of a liver screen
Microbiology: viral screen Clinical chemistry: ferritin/transferrin, lipids, caeruloplasmin, AFP, alpha-1-antitrypsin Immunology: autoantibodies Abdominal USS Consider Hep A+E, and hep B+D together
Hepatitis A aetiology
RNA picorna virus Transmitted feco-orally Incubation: 2-6w 80% asymptomatic Notifiable disease in UK Doesn't lead to chronic liver disease, so no carriers Typically affects children/young adults
Hepatitis E aetiology
RNA calcivirus Transmitted feco-orally Epidemics of acute, self-limiting hepatitis Common in indo-china Severe disease in pregnant women
Hepatitis B aetiology
Hepa-DNA virus
Transmitted in blood, semen, saliva via skin breaks/mucous membranes
Vertical transmission most common
Incubation period: 1-6m
Inner core (HBcAg) surrounded by outer envelope of surface protein (HBsAg)
10% develop chronic disease, 1% develop fulminant liver disease
Hepatitis D aetiology
Incomplete RNA virus
Only causes infection in presence of Hep B
Transmitted by bodily fluids, acute/chronic
Can be acquired simultaneously with hep B or later (more likely to develop fulminant liver disease)
Hepatitis C aetiology
RNA flavivirus, clinically similar to Hep B
Transmitted via bodily fluids, common in IVDUs
Vertical transmission rare, sexual transmission uncommon
Other viruses that can cause acute hepatitis
non A-E infections
CMV
yellow fever
HSV
Acute hepatitis pathology
Hepatocytes undergo degenerative changes (swelling + vacuolation) before necrosis + rapid removal
Necrosis maximal in zone 3 (centrilobular) as recieves least oxygenated blood
Scattered/periportal necrosis
Chronic hepatitis pathology
Hepatitis >6m
Principle cause of chronic liver disease, cirrhosis, hepatocellular carcinoma
Chronic inflammatory cell infiltrates are present in portal tracts
Loss of definition of the portal/periportal limiting plate, confluent necrosis, fibrosis –> cirrhosis
Severity: Child Pugh score
Serological markers of Hep B infection
HBsAg: marker of viral replication/active infection, appears within 6w, disappears 3m after
HBsAb: marker of previous cleared infection/immunisation
HBeAg: marker of a high degree of viral replication (high infectivity)
HBeAb: natural immunity to Hep B
HBcAb IgG: non-specific marker of current/previous infection
HBcAb IgM: infection within last 6 months
HBV PCR: marker of viraemia
Hepatitis immune tolerance/incubation phase markers
HBsAg +ve
HBeAg +ve
PCR +ve
transaminases -ve
Acute hepatitis markers
HBsAg +ve HBeAg +ve HBcAb IgG +ve HBcAb IgM +ve HBV PCR +ve HBsAg -ve
Chronic hepatitis markers
Acute markers +ve >6m
LFTs less deranged
HBeAg +ve
HBeAb -ve
Natural hepatitis immunity markers
HBsAg -ve
HBsAb +ve
HBcAg IgG +ve, IgM -ve
HBeAg -ve, HBeAb +ve
Vaccination to hepatitis markers
Only evidence of surface antibody immunity HBsAg -ve HBsAb +ve HBcAg IgG -ve, IgM -ve HBeAg -ve, HBeAb -ve
Acute viral hepatitis presentation
Pre-icteric: 1-2w prodrome of malaise, arthralgia, headache, anorexia, aversion to cigarette smoke, vague RUQ pain
Icteric: iteric (jaundice), pale stools, dark urine (intrahepatic cholestatic jaundice), pruritis, skin rash, lymphadenopathy, hepato/splenomegaly
Hep A+C: mild/no symptoms
Hep B has more extrahepatic symptoms
Acute alcoholic hepatitis presentation
Presents after binge: jaundice, RUQ pain, systemic upset
Signs of chronic liver disease
Discriminant function (DF): bilirubin, prothrombin, hepatic encephelopathy predict survival
AST:ALT>2 suggests alcoholic liver disease
Autoimmune hepatitis presentation
Commonly presents as chronic, 40% present as acute hepatitis with jaundice
Non-specific fatigue, arthralgia, fevers, weight loss
Age 15-25 or peri-menopausal
Associated with: primary biliary cirrhosis, primary sclerosing cholangitis, IBD)
Chronic hepatitis presentation
Asymptomatic
Complications: cirrhosis may cause symptoms
Diagnosed when serum ALT levels elevated for >6m
Paracetamol overdose pathology
Intrinsic hepatotoxin
Conjugated with glucuronide & sulphate at therapeutic doses
A small amount metabolised (oxidised) to form NAPQI
NAPQI immediately conjugated with glutathione due to its toxicity
In overdose, conjugation pathway becomes saturated = large amounts of NAPQI created which overwhelms liver glucothione stores causing cellular damage
Severity is dose-related
Paracetamol overdose presentation
Asymptomatic for 24h, maybe anorexia, nausea, vomiting
After 24h: RUQ pain, metabolic acidosis, hypotension, hypoglycaemia, pancreatitis, arrhythmia
Liver damage detectable on bloods >18h
Damage peaks 72-96h: deranged ALT/ALP & INR
Liver failure/acute tubular necrosis & renal failure can occur
Bilirubin metabolism
RBCs >120d destroyed in reticuloendothelial system of the spleen
Haem converted to biliverdin then to bilirubin, then bound by albumin (insoluble)
Protein-bound bilirubin taken up by hepatocytes –> conjugated by glucuronyl transferase to bilirubin glucuronide (soluble)
Soluble bilirubin excreted in the bile into the bowel where it is transformed by bacteria to urobilinogen
Urobilinogen exreted in stools, small amount reabsorbed and excreted by kidneys
Normal/jaundice levels of bilirubin
Normal upper limit: 25micromol/L
Jaundice: 50micromol/L
Pre-hepatic jaundice pathology
2ndary to increased erythrocyte breakdown (e.g. haemolysis/reabsoroption of large haematoma)
Bilirubin not yet been processed by the liver so mainly unconjugated
Cholestatic jaundice pathology
Bile outflow obstruction (cholestasis)
Intrahepatic: hepatitis, cirrhosis, neoplasm, drugs, pregnancy
Extrahepatic: gallstones, cholangiocarcinoma, primary sclerosing cholangitis, comgenital atresia of common bile duct, pancreatitis, tumour of pancreatic head
Mainly conjugated bilirubin, can give dark urine
Pale stools as none excreted into GI tract
Hepatocellular jaundice pathology
Hepatocyte dysfunction, partial inability to conjugate bilirubin
Mixed conjugated/unconjugated bilirubin in the blood
Causes: hepatitis, cirrhosis, neoplasm, hepatotoxic drugs
If severe: unconjugated hyperbilirubinaemia
Gilbert’s syndrome pathology
Congenital lack of gluconyltransferase
7% of population
Transient episodes of jaundice, especially following infection
Serum unconjugated bilirubin raised but LFTs and reticulocytes normal
Jaundice investigations
Bloods: FBC, reticulocytes, LFTs, U&Es, clotting, glucose, bilirubin levels
Transaminases most raused in hepatocellular jaundice/intrahepatic obstruction
ALP most raised in extrahepatic cholestasis
Glucose low in liver failure, high in pancreatitis
Urinary urobilinogen/bilirubin
Blood film/Coomb’s test: ?prehepatic jaundice
Viral serology/autoantibodies: ?hepatitis
USS: ?cholestasis cause
MRCP: biliary tree imagina
CT/MRI: demonstrate intrahepatic/pancreatic lesions
Needle biopsy: hepatic pathology
What types of cancer commonly metastasise to the liver?
Lung, stomach, colon, breast, uterus
Hepatocellular carcinoma pathology
90% of primary liver cancers
Common in China/sub-saharan Africa
Causes: chronic hepatitis, cirrhosis, metabolic liver diseases, aspergillus alfatoxin, parasites, anabolic steroids
Risk greater in males